Edition:
India

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

12.34USD
20 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$12.34
Open
$12.32
Day's High
$12.38
Day's Low
$12.09
Volume
133,158
Avg. Vol
266,376
52-wk High
$28.49
52-wk Low
$11.12

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.48 December 22 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 2
(2) OUTPERFORM 4 4 3 3
(3) HOLD 0 0 0 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.57 1.57 1.50 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 6 0.20 1.00 0.00 0.00
Quarter Ending Sep-18 6 0.03 0.19 0.00 0.00
Year Ending Dec-18 7 0.68 3.00 0.00 2.67
Year Ending Dec-19 5 1.60 5.00 0.00 17.39
Earnings (per share)
Quarter Ending Jun-18 6 -0.48 -0.43 -0.54 -0.43
Quarter Ending Sep-18 6 -0.53 -0.48 -0.65 -0.44
Year Ending Dec-18 7 -2.02 -1.88 -2.28 -2.20
Year Ending Dec-19 7 -2.15 -1.69 -2.55 -1.58

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 0.02 0.00 0.02 100.00
Quarter Ending Sep-17 0.19 0.00 0.19 100.00
Quarter Ending Jun-17 0.02 0.00 0.02 100.00
Quarter Ending Mar-17 0.03 0.91 0.89 3,544.00
Quarter Ending Dec-16 0.19 0.00 0.19 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.20 0.20 0.03 0.06 0.00
Quarter Ending Sep-18 0.03 0.03 0.03 0.05 0.00
Year Ending Dec-18 0.68 0.68 2.21 2.88 2.67
Year Ending Dec-19 1.60 1.60 2.15 2.57 17.39

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 1 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 1
Year Ending Dec-19 0 0 1 0
Earnings